Nextgen Biotech

Call us:

Dyronib 50mg - Dasatinib Tablets

Dyronib 50mg contains Dasatinib, a tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It helps in slowing the growth and spread of cancer cells.

  • ₹13000

Select your size:

Choose Quantity:

-
+
Share
General Information:
Generic Name: Dasatinib
Brand Name: Dyronib
Packing: Blister pack / Bottle
Strength: 50 mg
Manufacturer: Hetero Healthcare
Form: Oral Tablet
Category: Tyrosine Kinase Inhibitor (TKI) / Anti-Cancer Drug
Product Introduction:
Dyronib 50mg is an oral chemotherapy drug used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is a second-generation tyrosine kinase inhibitor (TKI) that works by blocking the abnormal proteins responsible for uncontrolled cancer cell growth, improving patient outcomes and survival rates.

Uses of Dyronib 50mg Tablet:
Dyronib 50mg is prescribed for:
  1. Chronic Myeloid Leukemia (CML) – Used in chronic and accelerated phases.
  2. Acute Lymphoblastic Leukemia (ALL) – Specifically for Philadelphia chromosome-positive (Ph+) cases.
  3. Patients Resistant to Imatinib – Effective in cases where Imatinib (first-line therapy) fails.
  4. Targeting Specific Leukemia Mutations – Used in patients with BCR-ABL gene mutations.
  5. Maintenance Therapy in Leukemia – Helps in long-term remission.
  6. Off-Label Uses – Under research for treatment of other cancers.

Storage Instructions:
  1. Store at room temperature (15°C – 30°C).
  2. Keep the tablets in their original packaging to protect from moisture.
  3. Keep out of reach of children and pets.
  4. Avoid direct exposure to heat and sunlight.
  5. Do not use expired tablets or tablets that appear discolored or damaged.

How Dyronib 50mg Works (Mechanism of Action):
Dasatinib is a tyrosine kinase inhibitor (TKI) that blocks the BCR-ABL fusion protein, which is responsible for uncontrolled cancer cell growth in Philadelphia chromosome-positive leukemia. By inhibiting this protein, Dyronib 50mg:
  1. Prevents the multiplication of cancer cells
  2. Slows down or stops tumor growth
  3. Induces programmed cell death (apoptosis) in leukemia cells

Side Effects:
Common Side Effects:
  1. Nausea and vomiting
  2. Diarrhea or constipation
  3. Fatigue and weakness
  4. Loss of appetite
  5. Headache
  6. Swelling in hands or feet (fluid retention)
Severe Side Effects (Rare but Serious):
  1. Low blood cell counts (Anemia, Neutropenia, Thrombocytopenia)
  2. Lung issues (Pleural Effusion, Pulmonary Hypertension) – Shortness of breath, chest pain
  3. Bleeding complications (Severe nosebleeds, gastrointestinal bleeding, internal bleeding)
  4. Heart problems (Irregular heartbeat, heart failure, high blood pressure)
  5. Liver or kidney dysfunction
  6. Severe infections due to low immunity
Seek immediate medical attention if you experience any severe side effects.

Dosage (Typical Recommended Dose):
For Chronic Myeloid Leukemia (CML):
  1. Chronic phase CML: 100 mg once daily
  2. Accelerated phase CML: 140 mg once daily
  3. If prescribed 50mg tablets, the dosage is adjusted accordingly.
For Acute Lymphoblastic Leukemia (ALL):
  1. Recommended dose: 140 mg once daily (dose modifications may be required).
Important:
  1. Dose adjustments may be required based on blood counts and tolerance.
  2. Do not stop taking without consulting a doctor.

Method of Administration:
  1. Take the tablet once daily with or without food.
  2. Swallow whole with water – do not crush, break, or chew the tablet.
  3. Avoid grapefruit juice, as it may increase drug toxicity.
  4. If you vomit after taking the tablet, do not take another dose—wait until the next scheduled dose.

Precautions:
  1. Regular blood tests are essential to monitor white blood cell count and platelet levels.
  2. Patients with heart conditions should use it cautiously.
  3. Avoid live vaccines while taking Dyronib 50mg, as your immune system may be weakened.
  4. Pregnant or breastfeeding women should not take this medication.
  5. Do not drive or operate heavy machinery if you experience dizziness or vision problems.

Drug Interactions:
Dyronib 50mg may interact with:
  1. Antacids (Proton Pump Inhibitors & H2 Blockers) – Avoid Omeprazole, Pantoprazole, Ranitidine, etc., as they reduce drug absorption.
  2. Blood Thinners (Warfarin, Aspirin, Clopidogrel) – Increases the risk of bleeding.
  3. Antifungal & Antibiotics (Ketoconazole, Clarithromycin, Rifampin) – May increase or decrease drug levels.
  4. Immunosuppressants & Chemotherapy Drugs – Can increase toxicity risk.
  5. Grapefruit juice – Avoid as it can raise drug levels in the body.
Always inform your doctor about all medications you are taking.

Allergies (Warnings for Allergic Reactions):
  1. Do not use if you are allergic to Dasatinib or any excipients in the formulation.
  2. Symptoms of an allergic reaction include rash, swelling, difficulty breathing, and dizziness.
  3. Seek emergency medical help if you experience severe allergic reactions.

Overdose Information:
Symptoms of overdose:
  1. Severe nausea, vomiting, and diarrhea
  2. Sudden drop in blood pressure
  3. Bleeding disorders
  4. Shortness of breath
What to do in case of overdose?
  1. Seek immediate medical attention.
  2. The doctor may provide supportive care or recommend dialysis in severe cases.

Missed Dose Instructions:
  1. If you miss a dose, take it as soon as you remember.
  2. If it is close to the next scheduled dose, skip the missed dose and continue the regular schedule.
  3. Do not double the dose to make up for the missed one.

Additional Notes:
  1. Regular blood tests are essential to monitor blood cell levels.
  2. Patients should avoid NSAIDs (like Ibuprofen or Diclofenac) to minimize bleeding risks.
  3. Long-term use requires periodic cardiac and lung function monitoring.
  4. Drink plenty of fluids to stay hydrated and reduce kidney stress.

In The Same Category

Cart